Paulson & Co. - SYNERGY PHARMACEUTICALS DEL ownership

Quarter-by-quarter ownership
Paulson & Co. ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2017$8,920,000
-87.2%
4,000,000
-83.4%
0.17%
-86.1%
Q3 2017$69,781,000
-34.9%
24,062,368
-0.1%
1.25%
-13.5%
Q2 2017$107,195,000
-4.5%
24,088,6550.0%1.45%
-2.8%
Q1 2017$112,253,000
-23.5%
24,088,6550.0%1.49%
-19.4%
Q4 2016$146,700,000
+9.9%
24,088,655
-0.6%
1.85%
+27.8%
Q3 2016$133,500,000
+26.6%
24,228,655
-12.7%
1.45%
+35.0%
Q2 2016$105,475,000
+244.6%
27,756,668
+150.3%
1.07%
+374.3%
Q1 2016$30,608,000
-40.0%
11,090,000
+23.2%
0.23%
-25.9%
Q4 2015$51,030,000
+7.0%
9,000,0000.0%0.30%
+23.0%
Q3 2015$47,700,000
-0.6%
9,000,000
+55.7%
0.25%
+12.2%
Q2 2015$47,986,000
+395.6%
5,781,500
+175.9%
0.22%
+351.0%
Q1 2015$9,682,0002,095,6000.05%
Other shareholders

There were no reported owners of SYNERGY PHARMACEUTICALS DEL in Q3 2023.

NameSharesValueWeighting ↓
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders